Health physics consequences of out-patient treatment of Non-Hodgkin's lymphoma with 131I-radiolabeled anti-B1 antibody

Health Physics

Volumn 79, Issue 5 SUPPL., 2000, Pages

  Ryan, M T ^a   Spicer, K M ^a   Frei Lahr, D ^a   Samei, E ^a   Frey, G D ^a   Hargrove, H ^a   Bloodworth, G ^a  

^a NONE   (United States)

Author keywords

Health effects; Medical radiation; Operational topics; Radiation therapy

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY I 131; RITUXIMAB;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; DOSIMETRY; FEMALE; HEALTH PHYSICS; HUMAN; MALE; NONHODGKIN LYMPHOMA; OUTPATIENT CARE; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY;

EID: 0033779408     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004032-200011001-00004     Document Type: Article

References (3)

1. Iodine-131 anti-B1 radioimmunotherapy for B-cell lymphoma
2. Successful re-treatment of non-Hodgkin's lymphoma (NHL) with iodine-131 Anti-B1 Antibody